FDA Inspection
MET Research, Inc.MET Research, Inc. – FDA Inspection, Jun 28, 2018
Record Details
This FDA Inspection record concerns MET Research, Inc., with an inspection on June 28, 2018, issued by the Detroit District Office, covering human drugs.
View Company Profile
ID · ab080376-2049-4164-8503-0f9bb8f1221e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1059224
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 58.130(e)Conduct: changes in automated data entries
- 21 CFR 58.185(a)(9)Final report: circumstances affecting data qual., integrity
- 21 CFR 58.33(b)Study director: all data recorded and verified
- 21 CFR 58.35(b)(5)QAU: authorize deviations from protocols or SOPs
- 21 CFR 58.41Facility: suitable size and construction
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MET Research, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 8, 2026 | Not classified | Detroit District Office | Bioresearch Monitoring |
| January 19, 2024 | Not classified | Detroit District Office | |
| March 8, 2019 | Not classified | Detroit District Office |
Other documents for MET Research, Inc.
- FDA Inspection 1321122 - 2026-06-08
- FDA Inspection 1231180 - 2024-01-19
- FDA Inspection 1086590 - 2019-03-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.